Recent TXG News
- 10x Genomics to Present at the BofA Securities 2024 Healthcare Conference • PR Newswire (US) • 05/02/2024 08:05:00 PM
- 10x Genomics Reports First Quarter 2024 Financial Results • PR Newswire (US) • 04/30/2024 08:05:00 PM
- 10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 • PR Newswire (US) • 04/10/2024 08:05:00 PM
- 10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay • PR Newswire (US) • 03/26/2024 01:00:00 PM
- 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel • PR Newswire (US) • 03/21/2024 08:05:00 PM
- 10x Genomics Begins Commercial Shipments of Chromium GEM-X Products • PR Newswire (US) • 03/13/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:12:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:40:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:13:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:12:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:12:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 12:19:58 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 12:06:30 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:59:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:20:30 PM
- 10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference • PR Newswire (US) • 02/20/2024 09:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/15/2024 10:33:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 10:16:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:05:40 PM
- 10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024 • PR Newswire (US) • 02/15/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:56:40 PM
- 10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology • PR Newswire (US) • 02/07/2024 09:05:00 PM
- 10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting • PR Newswire (US) • 02/05/2024 09:05:00 PM
- 10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 • PR Newswire (US) • 01/24/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:49:13 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM